QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,421 signal articles · 521 in last 24h · 104,630 total before filter · latest 1h ago
521last 24h
2512last 7d
480● bullish (7d)
256● bearish (7d)
198publishers
AllMacro192Earnings1542M&A138Regulatory16Product7Analyst28
✕ clear all filtersticker: CSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Jim Cramer Believes Citigroup (C) Is Fantastic
Insider Monkey65d agoneutral
Jim Cramer Believes Citigroup (C) Is Fantastic

We recently published Jim Cramer Warned About Market Manipulation & Discussed These 22 Stocks. Citigroup Inc. (NYSE:C) is one of the stocks discussed by Jim Cramer. Banking giant Citigroup Inc. (NYSE:C) was under the focus of several analysts in May. Goldman Sachs discussed the firm on May 9th. It reiterated a Buy rating and a […]

Investing.com65d agoneutral
Citi turns bullish on copper, sees price hitting $15,000 per ton within a year

Investing.com -- Citi has turned bullish on copper after several months of a broadly neutral stance, raising its near-term price forecast to $14,500 per metric ton and targeting $15,000 per ton within the next six to twelve months, driven by U.S. tariff tailwinds, tighter supply and resilient demand from energy transition and AI infrastructure.

PepsiCo (PEP) Extends Credit Facilities to Strengthen Long-Term Liquidity
Insider Monkey65d agoneutral
PepsiCo (PEP) Extends Credit Facilities to Strengthen Long-Term Liquidity

PepsiCo, Inc. (NASDAQ:PEP) is one of the 10 Safest Dividend Stocks to Buy Right Now. PepsiCo, Inc. (NASDAQ:PEP) restructured its credit facilities on May 22, 2026, to maintain short- and long-term liquidity. The company replaced its existing $5 billion 364-day unsecured revolving credit facility with a new one expiring May 21, 2027. At the same […]

Is Fannie Mae’s Latest Reperforming Loan Sale With Citigroup Quietly Reshaping FNMA’s Risk Profile?
Simply Wall St.66d agoneutral
Is Fannie Mae’s Latest Reperforming Loan Sale With Citigroup Quietly Reshaping FNMA’s Risk Profile?

In late May 2026, Fannie Mae announced it had begun marketing a pool of about 2,333 reperforming loans, with bids due on June 23, 2026, working alongside Citigroup Global Markets. This move highlights how Fannie Mae actively reshapes its mortgage exposure through whole-loan sales, potentially influencing its risk profile and balance sheet mix. Next, we will examine how selling reperforming loans in partnership with Citigroup could affect Fannie Mae’s broader investment narrative. Invest in...

How The Investment Story Is Shifting For Niu Technologies (NIU) After The Latest Analyst Reset
Simply Wall St.66d agoneutral
How The Investment Story Is Shifting For Niu Technologies (NIU) After The Latest Analyst Reset

Niu Technologies is back in focus after analysts reset their fair value estimate from US$4.65 to US$3.10, prompting a revised price target of US$3.50. This latest move sits alongside a Neutral rating and reflects updated assumptions that analysts see as balancing potential upside with ongoing risks. Looking ahead, you will see how this evolving analyst narrative, plus the company’s own guidance, can shape how you track the stock from here. Analyst Price Targets don't always capture the full...

Investing.com66d agoneutral
Could GLP-1 drugs become oncology’s next big opportunity?

Investing.com -- GLP-1 weight-loss and diabetes drugs may have a future role in cancer prevention and treatment, according to new research highlighted by Citi ahead of the 2026 American Society of Clinical Oncology (ASCO) meeting, adding another potential growth avenue to an already booming drug class.

A Look At Citigroup (C) Valuation As Shares Deliver Strong Recent Returns
Simply Wall St.66d agoneutral
A Look At Citigroup (C) Valuation As Shares Deliver Strong Recent Returns

Citigroup (C) is back in focus after recent trading, giving investors fresh data to weigh alongside its long track record as a global bank and its current share price of US$125.90. See our latest analysis for Citigroup. At a share price of US$125.90, Citigroup has delivered a 6.1% year to date share price return. The 1 year total shareholder return of 70.9%, along with a 3 year total shareholder return of about 3x, highlight strong momentum following a softer 1 month share price return. If...

Here’s What Citi Thinks About Grupo Aeroportuario del Centro Norte (OMAB)
Insider Monkey66d agoneutral
Here’s What Citi Thinks About Grupo Aeroportuario del Centro Norte (OMAB)

Grupo Aeroportuario del Centro Norte, S.A.B. de C.V. (NASDAQ:OMAB) is one of the Best Airport Stocks to Buy According to Hedge Funds. On May 8, Citi upgraded Grupo Aeroportuario del Centro Norte, S.A.B. de C.V. (NASDAQ:OMAB) from Neutral to Buy and kept the price target unchanged at MXN 270. The firm noted that the stock […]

Paramount Is Pulling Every Lever to Sell LBO Debt
Bloomberg67d agobearish
Paramount Is Pulling Every Lever to Sell LBO Debt

(Bloomberg) -- Paramount Skydance Corp. stretched, then stretched, then stretched again in its audacious $110 billion takeover bid for Warner Bros. Discovery Inc.Most Read from BloombergAmericans Injured in Iranian Missile Strike on Kuwaiti Air BaseStrait of Hormuz Ship Transits Are Rising Thanks to US HelpCVS Returns Zepbound to Drug Plans After Lilly Slashes PriceAmericans Hurt in Kuwait as Trump Sends Mixed Signals on WarSingapore Hands Byju's Founder His First Ever Jail TermNow the companies

Bloomberg68d agoneutral
Danish Pension Blacklists SpaceX Over ‘Catastrophic Governance’

(Bloomberg) -- A $25 billion Danish pension fund that earlier this year made headlines by ditching Treasuries as Donald Trump was threatening to seize Greenland now says it won’t touch SpaceX.Most Read from BloombergSingapore Hands Byju's Founder His First Ever Jail TermStrait of Hormuz Ship Transits Are Rising Thanks to Help From USCVS Returns Zepbound to Drug Plans After Lilly Slashes PriceApple to Overhaul iOS 27 Siri, AI Features: Here's a First PeekSpaceX Said to Cut IPO Value Goal to at Le

Bloomberg69d agoneutral
SpaceX Lowers IPO Valuation Target to at Least $1.8 Trillion

(Bloomberg) -- SpaceX is currently targeting a valuation of at least $1.8 trillion in its initial public offering, according to people familiar with the matter, as Elon Musk’s rocket and artificial intelligence company nears its debut.Most Read from BloombergSingapore Hands Byju's Founder His First Ever Jail TermApple to Overhaul iOS 27 Siri, AI Features: Here's a First PeekIran’s Khamenei Says No Going Back for Middle East Rocked by WarCVS Returns Zepbound to Drug Plans After Lilly Slashes Pric

Why The Story Around Ionis Pharmaceuticals (IONS) Is Shifting After Fresh Analyst Targets And Guidance
Simply Wall St.69d agoneutral
Why The Story Around Ionis Pharmaceuticals (IONS) Is Shifting After Fresh Analyst Targets And Guidance

The fair value estimate for Ionis Pharmaceuticals has shifted from US$96.73 to US$100.92, a modest reset that puts fresh numbers around the stock. This move comes during an active period of Street research, with some firms lifting targets and others trimming them, reflecting different views on how to factor pipeline milestones and revenue guidance into valuation work. As you read on, you will see what is driving these updates and how to keep track of the evolving analyst narrative around...

​Citigroup Inc. (C) Anchors Wealth Hiring in Asia
Insider Monkey69d agoneutral
​Citigroup Inc. (C) Anchors Wealth Hiring in Asia

Citigroup Inc. (NYSE:C) is one of the best 52-week high stocks to invest in, according to short sellers. On May 22, Reuters reported that Citigroup Inc. (NYSE:C) plans to direct much of its global wealth management hiring to Asia, where its private bank is expanding faster and proving more productive than in other regions. Global […]